Evidence map›Paper›PMID 31767720›Full record

ArticleAntimicrobial agents and chemotherapy2020

High Heterogeneity of Multidrug-Resistant

Ana Djukovic, Eva M González-Barberá, Jaime Sanz, Alejandro Artacho, Iván Peñaranda, Beatriz Herrera, María José Garzón, Miguel Salavert, José Luis López-Hontangas, Karina B Xavier and 6 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Ana DjukovicCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.
Eva M González-Barberá *Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Jaime Sanz *Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Alejandro ArtachoCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.
Iván PeñarandaCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.
Beatriz HerreraCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.
María José GarzónCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.
Miguel SalavertHospital Universitari i Politècnic La Fe, Valencia, Spain.
José Luis López-HontangasHospital Universitari i Politècnic La Fe, Valencia, Spain.
Karina B XavierInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0001-5210-1434
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Laurent DebrauwerToxalim-Research Center in Food Toxicology, Toulouse University, INRA UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.
Jean-Marc RolainAix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Miguel A SanzHospital Universitari i Politècnic La Fe, Valencia, Spain.
Joao B XavierLucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Carles UbedaCentro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain ubeda_carmor@gva.es.
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital Universitari i Politècnic La Fe · ESInstituto de Salud Carlos III · ESInstituto Gulbenkian de Ciência · PTMéditerranée Infection Foundation · FRMemorial Sloan Kettering Cancer Center · USTechnical University of Munich · DEUniversité Toulouse III - Paul Sabatier · FR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant PathogensU01AI124275 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI PAMER, ERIC G., XAVIER, JOAO · 2016 to 2020
$8.9M
Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT)R01AI137269 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TAUR, YING, XAVIER, JOAO · 2019 to 2023
$3.8M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI137269NIAID NIH HHS U01 AI124275
6 · The paper itself

Abstract

Multidrug-resistant

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial Agentsbeta-LactamsCephalosporinsCulture MediaEnterobacteriaceaeFecesHospitalizationHumansInjections, IntravenousLeukemiaMicrobial Sensitivity TestsProspective StudiesAnti-Bacterial Agentsbeta-LactamsCephalosporinsCulture Mediaantibiotic resistancebeta-lactamsEnterobacteriaceaeintestinal colonization

Identifiers

PMID31767720
PMCPMC6985730
OpenAlexW2990791589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.